PacBio reports that through its partnership with China-headquartered Berry Genomics, the Sequel II CNDx system has received Class III Medical Device Registration approval from the National Medical ...
MENLO PARK, Calif. and PRETORIA, South Africa, April 20, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced an expanded partnership with seqWell yesterday. Under the new agreement, PacBio will distribute seqWell’s LongPlex ...
MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), developer of the world's most advanced sequencing technologies, today announced that, through its long-standing partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results